Bellwether Magazine
Volume 1
Number 43 Summer 1998

Article 18

Summer 1998

28th Annual Canine Symposium
Joan Capuzzi
University of Pennsylvania

Follow this and additional works at: https://repository.upenn.edu/bellwether

Recommended Citation
Capuzzi, Joan (1998) "28th Annual Canine Symposium," Bellwether Magazine: Vol. 1 : No. 43 , Article 18.
Available at: https://repository.upenn.edu/bellwether/vol1/iss43/18

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/bellwether/vol1/iss43/18
For more information, please contact repository@pobox.upenn.edu.

Canine Symposium
Cancer in Dogs

T

he 28th Ann ual Canine Sy mpo
siu m was held January 31 . 1998
at VHUP. T he e ent was organ
ized wi th th help of the School's Mari
Lowe Center for Comparative O ncology
and featured a series of presentations on
Cane r in Dogs.

Man Lowe Center for
Comparative Oncology
The words can cer and growth are bru
tally intertwined. But they are also con
nected in several positive ways, said Dr.
Narayan G . Avadhani . professor of bio
chemistry at th Sc hool. In recent years,
cancer has m t treme ndous growth in re
search, knowledge , technology and treat
ment modal ities . Dr. Avadhani presented
Penn 's Mari Lowe Center for Compara
tive Oncol ogy. wh ich conducts extensive
cancer research and c1 inicaJ programs .
Cancer is a g n tic disease, Dr.
Avadhan i xplained. Yet cancer is in
herited in only fi ve percent of case s. The
re t spon taneously arise follo wi ng a pri 
mary DNA lesion that occ urs during the
life of an indivi dual. "It is this 9S percent
of the population that's go ing to be ex
tremely important for understanding can
cer in both humans and animals.
" Animals are exposed to the same en
vi ro nment and some of the same putative
cau sal factors that we are: ' he said.
With these issues in mind, the Center,
whic h is supported primarily through in
dividual and found aLl on contributions,
has created a state-of-the-art clinical on
cology service at VHUP and today trains
veterinary oncologists, conducts
multidisciplinary re 'earch and supports
outside cancer research. Si nce its estab
lishment four years ago, said Dr.
Avadhani, who heads the Center, the
n umber of canine cancer patients at
VHUP bas more than doubled to some
1,500 cases annually.
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Cancer Terminology
and Symptoms
What exactly is cancer? The language
used to discuss cancer and its Lreatment
is composed of many words that are not
part of everyday conversation. Dr. Kim
Cronin introduced some of the basic ter
minology that veterinary cancer special
ists use and also discussed the early
warning signs of cancer to help the sym
posium audience prepare for the lectu res
that would follow.
The early warning signs of cancer in
small animals are similar to the seven
warning signs of cancer in people used
by the Americ an Cancer Society. The
signs range from: an abnormal swelling
that persists or continues to grow, a sore
that does not heal, weight loss, bleeding
or a discharge from any body opening,
reluctance to exercise, a loss of stamina
or difficulty breathing, urinating or def
ecating. Even subtle changes , such as
sleeping more, not pl aying as much and
lack of desire to interact may indicate the
need for a veterinary evaluation to deter
mine if additional tests are necessary.
The term neoplasia means new
growth and is used interchangeably with
cancer. It takes about a billion cells, or
thirty doublings, before we can actually
see a tumor. When rapidly dividing can
cer cells invade normal tissue the cancer
becomes malignant. Malignant cancers
can metastasize - spread to other parts
of the body. During metastasis the cancer
cells move through the blood stream or
lymphatic vessels and may settle in tis
sues distant from their origin. The loca
tion where the tumor grew before
metastasizing is called the pri mary site.
Benign tumors are not usually invasive
and do not metastasize.
The lungs and lymph nodes are the
most common sites for tumor metastasis,
however, there are many types of cancer
that selectively spread to other parts of
the body. The way a tumor grows and
spreads is called its biologic behavior.
The biologic behavior of a tumor deter
mines what tests will be performed, how

the animal will be treated therapeutically
and what the probable outcome will be.
There are many uniq ue terms u 'ed to
describe the procedu res involved in the
clinical workup of an animal with cancer.
An aspiration is when a needle attached
to a syringe is in serted into the tumor
and the plunger on the syringe is draw n
back to suction a few cells from the mass
for microscopic analysis . Cytology refers
to the examination of the cells collected
by aspirate . biopsy involves the surgi
cal removal of a small piece of tiss ue and
examining it under the microscope.
Grading of tumors is accomplished by
characterizing the tumor cells usi ng the
microscope. Tumors are assigned into
high , intermediate and low grades based
on microscopic evaluation. Hi gh grade
tumors tend to be very aggressive, they
spread early and are difficult to treat.
Low grade tumors are exactly the oppo
site . Staging is the evaluation of the ex
tent of the tumor and the prognosis is the
expected outcome for that tumor. A pro
tocol is the overall treatment pl an , the
drugs used , how often as well as the
number of times repeated. Fi nally, when
the bone marrow is no longer able to
produce normal cells the patient loses the
ability to fight infection and sepsis re
sults. Sepsis is an overwhelming sys
temic infection. Recognizing the early
warning signs of cancer may lead to
early detection and significantly in
creases the likelihood of success ful
treatment.

M.R.

Cancer Detection through
Imaging Studies
Im aging techniques are indi spensable
in the management of cancer in domestic
animals. Dr. Jeffrey A. Wortman, associ
ate professor of radiology at the School ,
discussed the applications of various im
aging modalities in diagnosing cancers,
assessing prognoses, planning treatments
and monitoring disease response .
Diagnostic imaging techniques, such
as radiography - or "x-rays," are used
for cancer screening , detection , staging
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and surveill ance. Screening tests are em
ployed to detect cancer in a population
prior to the onset of clinical signs; unlike
in people, in whom screen ing tests like
routine mammography are often per
formed, these tests are infrequently done
in animals. Imaging studies are ro uti nely
used to detect the presence of neoplasia
in clinically-affected animals. T hese
studies have variable sensitivi ties and
specificities for diagnosing different tu
mor types; additional tests like tissue bi
opsy are often added to augment imaging
studies.
Imaging tests also serve in staging of
cancers. Once the diagnosis is confi rmed
by histopathology, such imaging diag
nostics as thoracic radiography can then
be used to detect tumor metastasis from
primary sites, such as bone; these " mets"
show up as radiopaque (white) nodules.
Thi s infonnation is important in affixing
prognosis and planning treatments like
surgery, radia tion therapy and chemo
therapy. " If the cancer has spread:' said
Dr. Wortman, " this indicates that it 's ag
gressive and will be more difficult to
treat and cure."
ollow-up imaging studies can then be
incorporated into disease surveillance to
chronicle disease regression , progression ,
relapse, and treatment complications.
T he imaging methods that are particu
larly efficacious in veterinary oncology
include radiography +/- contrast (i.e. io
dinated agents) ultrasound, x-ray com
puted tomography (CT), magnetic
resonance imaging (MRI) and nuclear
sci ntigraphy (scans). The choice of imag
ing study, Dr. Wortman explained, "de
pends on many things, like the patient
hi story and (tentative) diagnosi s, which
will give us some idea of the nature of
the cancer and its biological behavior."
The choice also depends on what infor
mation is being sought, availability and
quality of the imaging technology and
expertise of the veterinarian interpreting
the study.
Ultrasonography, an imaging tech
nique in which deep structures of the
body are visualized by recording the re
flection s of sound waves directed into
the tissues, enables one to view masses
that mayor may not be externally pal

pable. It can also be used to safely direct
biopsy instruments to internal sites so
ti ssue samples can be obtained for pa
thology. Likewise, a CT scan or an MRJ
may elucidate a brain tumor that would
not be apparent on skull radiograp hs. The
availability of imaging modalities in vet
erinary medicine is variable. Radiogra
phy, incl uding contrast techniques, is
ubiquitous throughout pri vate veterinary
practice, said Dr. Wortman, and ultra
sound is steadily becoming more acces
sible. But more sophisticated studies,
like CT and MRI, are less accessible to
animal patients.
Whatever imagin g testes) one selects
to screen for. diagnose, stage or monitor
cancer, Dr. Wortman adv ised, one should
maximize the fitness of the test by using
proper technique. In radiography this in
cludes correct body positioning and fi lm
exposure, and use of contrast agents
where appropriate.
" You need to be awa re of the limita
tions of a specific test and try to expand
on the test in order to accurate ly make
the diagnosi s."

I e.

Breed Related Callcers
Many cancers have been fou nd to
have a breed predilection . Dr. M ichael H.
Goldschmidt, professor of pathology at
the Sch ool and head of the Surgical Pa
thology Service of the Laboratory of Pa
thology and Toxicology, showed
examples of specific cancers in the dog
and the breeds most commonly affected.
Dr. Goldschmidt cited a study con
ducted in the 1960's in the USA that esti
mated tumor incidence at about 1. 100
cases per 100,000 dogs per year. T he
Laboratory of P athology had developed
an extensive computerized database of
canine cases ; in the decade preceding
1995 over 130,000 cases in dogs were
submitted to the Surgical Pathology Ser
vice for diagnosi s. Most tumors in these
dogs were fro m the skin , oral cavity,
mammary gland and male genitalia. Be
cause of the large size of the database it
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was often possible to calculate the breed
risk for commonly diagnosed tumors.
An example of this w a ~ mammary tu
mors. Benign mammary tumo rs, seen
clinically as well encapsulated masses of
varying size and consistency on palpa
ti on, were found to have a higher predi
lection for small breeds of dogs snch as
the miniature pood le, Yorks hire terrier,
Chihuahua and Maltese_ Malignant
mammary tumors, seen clinicall y as in
vasive, infla med, ulcerated masses with
lymphatic invasion in some cases, had a
higher predilectio n in the English setter.
Chihuahua, miniature poodle and Afghan
ho und. Many breeds at dec reased risk for
developing mammary tumors, such as
the golden retrie ver. Rottweiler and
boxer were at high risk for developing
soft ti ssue and mesenchymal tumors.
The incidence and types of tumors are
breed related and probably controlled by
a si ngle or multiple genes. An example
given was the German shepherd which is
predisposed to developing nodul ar
dermatofibrosis, a syndrome that is com
pri sed of a three tu mor; mu ltiple dermal
fi bromas (multiple fi nn masses in the
skin), renal cy stadenocarcinomas (malig
nant cystic epitheli al tumors throughout
the kidneys), and in females uterine
leiomyomas (benign tu mors of the
smooth muscle).
Dr. Go ldschmidt also illustrated the
increased and decreased breed risks asso
ciated with two speci fic skin tumors , in
cluding infundibular keratinizing
acanthoma, to which the Norwegian
elkhound is highly predisposed with a
rel ative ri sk of 29. and tri choblastoma, to
which the Keny blue terrier is predis
posed with a relative risk of 12.
Otiler specific tumors with high breed
risks were also d iscu ssed. These included :
• Trichoepitheliom a: basset hound
• Pil omaticoma : Kerry blue terrier
• Ceruminous adenoma: cocker spaniel
• Anal sac gland carcinom a: English
cocker spani el
• Subungual squamous cell carcinoma:
giant schnauzer and Gordon setter
• Subungual malignant melanoma:
Scottish terri er

(contin ued on page 22)
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• Melanocytoma : Vizs la and miniature
schnauzer
• Liposa rcoma: Shelland ~heepdog
• Mast cell tu mor: boxer and pug
• C utaneo us plasmacyt ma: cock r
\paniel
Dr. Gold sc hmidt concluded that by
selecting for the specific extern al fea
tures of a dog. its p heno ty pe, we are se
lecting spec ific genes, which make that
breed more or less susceplib le to devel
oping a specific cance r.

Ie

Cancer Treatment Options
When it com s to treating cancer,
quant ity and quality should go hand-in
hand . Dr. Karin Sorc nmo, ass is tant pro
fessor of oncolog at the School , sa id
that cancer therapy is best governed by
attempts to prolong life within the realm
of maintaining reasonable qual ity of ex
istence. "We try to m aintain the highest
degree of functio n and take as few risks
for seriou complication s as poss ible"
when planning cancer treatment proto
cols, she sa id.
Several factors infl uence cancer treat
ment decisions . Most importan t are the
tu mor type, biological behavior and stag
ing. Malignant tumors are characterized
by local invasion +1- di stant metastasis.
Highly malignant (high grade) tumors
ofte n have me tas lasiz d by the time the
pati en t's cancer is diagnosed. For high
grade tumors , aggressive treatment com
bini ng surgery and chel lotherapy is
often warranted even if metastases are
no t yet detectable radiographically. T he
goal then is not typically to cure, but
rather to prolong su rvi val by ~ lowing
di sease p rogress ion and to provide pal
liation. O n the other hand, tumors th at
are locally invasive bu t less likely to
spread offer better prognoses and are of
ten treated effecti vel y w ith surgery andl
or radiation therapy.
T he patien t's overall health status
plays a major role in lherap choices.
Concurrent diseases should be attended
to and the patient evaluated for its ability
to tolerate cancer treatme nt. Life expect
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anc y should be taken into consideration
as wel l; for a slow-grow ing tumor in an
older dog, for example , the treatment
drawbacks may outpace the potential
benefi ts .
Ow ner fac tors also impact med ical
decisions because treati ng cancer re
quires the owner's money, commitment
and emotional resilience.
The three principal cancer treatment
modalities are surgery, radiation therapy
and chemotherapy. Su rgery has two
functions in cancer management: to ob
tain tissue biopsies for definitive di ag no
sis and to excise les ions completely.
Biopsy provi des information about the
mitotic index and vascularity of the tu
mor, both of which are increased in rap
idly-g rowing masses. Local lymph nodes
can also be biopsied to detect evidence
of tumor spreading.
Tumor excision is perfonned for both
curative and - in the case of painful tu
mors like osteosarcomas - pall iative
reasons. Tu mors are resected with wide
margins; the objective is to obtain
"clean" or cancer-free borders, thereby
minimizing the likelihood of local recur
rence. O nce the lesion is e cised, the
borders are examined histologically for
the presence of neoplastic cells.
Radi ation therapy is a suitable alte r
native to radical surgery for tumors in
certain locations, such as the head or
legs. Rad iation is also important for ad
junctive treatment of tumors that are not
completely resectab le, as weJl as for lo
cally-invasive tumors like nasal carci no
mas, for which surgery alone is usually
not curati ve. As an adjunct to su rgery, ra
diation therapy is effectiv e in steril izi ng
the borders. If the borders are clean, the
mai n concern then becomes distant meta 
stasi s.
C hemotherapy is often combined with
surgery or radiation therap y to treat high
grade tumors that are likely to metasta
size. In addition, it 's the treatment of
choice for multicentric cancers like leu
kemia or lymphosarcoma..:hemotherapy
strikes rapidly-dividing celts, which, in
addition to cancer cell s, include normal
cells of the bone marrow, oral mucosa
and G .l. tract. Many owners fear poten
tial chemotherapy side effects. However,

those seen in people, such as hair loss
and nau sea , are not typi ca lly experienced
by dogs. Because most breeds do not
have contin uou sly-growing ha ir, the h ai r
folli cular cells are not affected by che
motherapy. More importantly, the objec
tive for most canine cancer patien ts is to
prolong life rather than establish a cure.
Therefore, low er doses and fewer drug
co mbinations are used.
" If we treat aggressively and cause se
riou s complications in these normal tis
sues, all the while knowing we are not
going to cure the animal," Dr. Sorenmo
explained, "then we probably haven ' t
done that animal a favor."
Veterinarians administer the same
chemotherapy drugs used in human on
cology. The drugs are given orally, intra
venously or subcutaneously. Ex tensive
owner cooperation is necessary in com
plying with strict and sometimes rigor
ou s treatment schedules. But the returns
can be weJl worth the effort. Dr.
Sorenmo pointed out that chemotherapy
extends the average lymphosarcoma sur
vival time from just two months (un
treated) to a year; ten to 15 percent of
these cases never relapse. For osteosar
coma, following surgery with chemo
therapy doubles the survi val time over
amputation alone.
In designing a cancer treatment proto
col utilizing any or all of the aforemen
tioned option s, one must first define the
tre atment goal based on a realisti c prog
nosis. T his determines acceptable level s
of owner resources spent and patient dis
comfort tolerated . D r. Sorenmo cau
tioned: "The treatment should not be
worse than the disease itself."

i.e.

Quality of Life Issues for
Cani1le Cancer Patients
"Quality of life concern s are impor
tant to ve teri narians who want their pa
tients to feel good, they are important to
pet owners because pet;; are often consid
ered family members, and quality o f life
is certainly important to our patients" ex
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plained Dr. Lillian Duda , lecturer in ra·
diation oncology.
O nce a diagnosis of cancer is made ,
tbe decision to pursue treatment hinges
on the determination of the quality of life
that can be expected for the animal fro m
that point onward. The veterinarian can
help the pet owner feel comfortable talk
ing about th e many issues invol ved, and
the y must work together toward a com
mon goal. It is something that should
also be discu ssed between fam il y mem
bers and fri e nds becau se the malleI' is
both personal and emotionally charged.
The main goal in cancer treatment is
to secure a high quality of life for as long
as possible. A pet may be kept alive in
the hospital usin g supportive measures
such as oxygen and intravenous flu ids,
but, it may not be acceptable to do so if
there is no hope of improving the pet
enou gh that it can go home. Quality of
life issues are more easily overlooked
and more diffic ult to assess than quantity
of life issues. T here must be a balance
between both. The veterinarian can help
by remaining objective and providing in
formation about the canc er and the ef
fects of treatments on the animal.
However, the veterinarian depends on
the owner to report how their pet is feel
in g and behaving.
T he side effects of cancer therapy are
numerou s and vary greatly bet ween pa
tients. In general, it is not acceptable to
expect the al1imal to suffer side effects
from the treatmcnt without a good
chance of a belicf life. The Animal Medi
cal Center in New York City has devel
oped a scale to asses s the overall quality
of life for dogs undergoing cancer treat
ment. They measure the dog's ability to
carry out normal daily activities using
five parameters. Eating is one of the pa
rameters that is measured. As their qual
ity of life begins to decrease, dogs will
often show changes in their eating habits
or may have a general loss of appetite,
some other parameters are alertness,
body condition ~. ti nd activity level. This
scoring method makes the difficult task
of assess ing the dog's condition more
objective and provides useful medica l in
formation. Studies have shown that indi

viduals scoring closer to normal tend to
do better overall.
Quality of life means something differ
ent to each pet owner. People are asked to
come up wi th and write down their per
sonal minim um level of acceptable qual
ity or life for their pet before it receives
treatment. This is done to help them an
ticipate, and thereby prepare for some of
the important dec isions they may need to
make. If the unanimous goal is to prolong
a quality life and to minimize suffering
then euthanasia is some times the only op
tion remaining . Euthanasia is a humane
and responsi ble decision - a final
therapy aJlowing the pet to be released
fro m pain and suffering.
/'vf.R ..

Nutritiollal Needs of
Canine Cancer Patients
Ani mals with seri ous chronic illness
are often malnourished . On e of th e pri
mary reasons this occurs is because their
appetites are impaired by the illness and
oftentimes the on ly food they accept 
table foo d - is nu tri tionall y in adequate.
T his may not be cri ti cal for short periods
of time, but. when treatments ex te nd for
weeks or even month s there can be seri
ous effects on the ani mal 's health related
to malnourishment. "1 like to tell peo ple
it is their job to find something the ir dog
will eat adeq uate amounts of consi stently
and I can bu ild a balanced diet aroun d
it," said Dr. Kathryn Michel. ass istan t
profe ssor of nutrition . Cancer not only
affects the patient's quality of life , but,
can also impair their abi li ty to tolerate
cancer treatments. Meeting the unique
need s of patients un dergoing cancer
therapy is augmented by providi ng ad
equate nutrition, however, dietary
therapy in this context is consi dered sup
portive rather than primary care.
D r. M ichel re viewed the six basic
classes of nutrients. "I know that we
don ' t normally think of water as a nutri
ent but really it is the most essential nu
tr ie nt the re is . An animal will die of
dehydration in a muc h shorter time than
it w ill die from starvation. " After water,

the body must ha ve nutrients that p ro
vide energy sllch as carbohydrates. fats
and protein. Protein not on ly suppl ies
calories, it is also the source of amjno ac
ids whic h the body uses to make new
proteins. Micronutri e nts are also deri ved
from the m inerals and vitamins in the
diet. A dog with cance r will req uire wa
ter, adeq uate calori es, p ro tei n, minerals
and vitLU11ins, however, cancer cau ses
changes in normal met abolism that are
not overcome by supplying calories and
nutrie nts. At this li me the spec ific nutri
tional req uire menb for dogs wi th cancer
have not been established.
C ancer the rapies that reduce the
chances of deleteriolls side effects are al
ways sought, but, they are not always
completely successful. Some patients
may have nausea. vomiting or diarrhea
as a result of their trea tment. If an animal
associates side effects such as nausea
wi lh the act of eating they may stop eat
ing fo r that reason. This phen ome non is
termed a learned food aversion and pre
sents qu ite a challenge when we try to
feed these ani mals. An im portant part of
nursing a dog or cat th rough an illness is
coaxed feeding. It is very important not
to push food on an animal that does not
want to eat. [t is best to wa it until the pet
is com fortab le and not stressed before
presenting food. D o not attempt feed ing
righ t after changing bandages or giving
med ications . It may be best to feed them
cold food directl y from the refrige rator,
as it w ill not have much taste or aroma.
Drugs may be useLi to reduce nausea as a
sh ort term approach if the dog~ are hav
ing gastroi ntesti nal "i de effects . Appeti te
stimulan ts are most useful in con vales
cent ani mals to "j um p-start" their appe
tites. but , rea lly have very li mited
application. T he y are not intended for
long term use. If the dog shows some in
terest in food try feeding novel food
items or offer foo d in a di fferent setting
or at differen t limes. You can also divide
the day's food up into a number of small
meals instead of one or two large ones.
Some patien ts may be nefi t from nutri
tio nal support. These patients often show
signs of malnouri shmen t and have not re
sponded well to coaxed feeding. It may
(continu ed on page 24)
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be necessary to feed these dogs using a
nasoesophagealor es phag al tube. In
critical patients intra en ous feeding is
given to help an ima ls through a short
ti me period until the che motherapy takes
effect. Th is i::; nnt complete nutritional
su ppo rt, nor is it mean t to be used as life
support. It is providing adeq uate nutri
tional care for a li mited time to cancer
patients who are unable to nourish them
sel ves duri ng the treatm ent of their
di sease .
M.R.

Canine Osteosarcoma
Osteosarcoma is the most common
primary bone tumor in dogs. accounting
for some 85 percent of canine bone tu
mors . VHUP clini cal spec ia list Drs .
Kim Cronin and Amy Kapatk in ex
plained the disease process of - and
treatments for steosarcoma.
T he average Sleosarcoma patient is
seven or eight years of age, al though
dogs as young as six months old have
been diagnosed with this cancer. It typi
cally strikes large- and giant-breed dogs
like great D anes, golden retrievers and
German 'hepherds. Associated with high
amounts of stn:ss on weight- bearing
limbs, osteosarcoma is almost 500 times
as likely to affec t dogs over 35 kg than
dogs weighing less tha n 10 kg.
Os teosarcom a::; tend to anchor them
selves in areas of increased bone remod
eling, said Dr. Cronin, lec tu rer in
oncology. "Every time you have cell
damage or increast!d turnover, the DNA
is more likel to make a mistake when
coding for new cells. which can lead to
tumor formation ." So nat urally, previous
fractures and chronic bone infections are
predisposing factors. These tumors are
more likely to occ ur in the li mbs, par
ticularly the forelim bs, which bear most
of the body weight; other bones, such as
the ribs and skull, can also be affected.
Osteosarcoma is both locally invasive
and metastatic. It infiltrat s the bone and
weakens it. It then spreads throughout
the body. T he chief presenting signs for
osteosarcoma are lamenes s and pain
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(which may be intermittent) , limb swell
ings and pathologic fractures at the
tu mo r site.
Because osteosarcoma shares com
mon clinical signs wi th other conditions
like degenerati ve j oint disease (arthritis),
infectious diseases and other tumors of
the bone (i.e. fibrosarcoma, chondrosar
coma, hemangiosarcoma and synovial
cell tumor), a thorough physical exam,
radiographs and biopsy are used to make
the fin al diagnosis. Ch st radiographs
should be performed in dogs diagnosed
with osteosarcoma. Accordi ng to Dr.
Cronin, over 90 percent of afflicted dogs
have pulmonary metastasis at the time of
diag nosi , although lung nodu les may
not yet be visib le rad iographically.
Because of its high metastatic poten
tial, osteosarcoma carries a guarded
prognosis. Most patients ventually die
of meta ·tas is to the lungs or other or
gans. The average surv ival time from the
date of diagnosi s is 8-12 months. Only
20 percent of patients are alive two years
after diagnosis. Without treatment, m ost
patients succ umb to the di sease within a
couple of months.
Treatment is aimed at removing neo
pia tic sites and preventing further seed
ing. If the tumor is on a leg, am putation
is the usual course. "We must be ery ag
gressive in our initial approach so we
do n't get regrowth ," sai d Dr. Kapatki n,
assistant professor of orthopedics and
neurosurgery. The leg i<.; typic ally disar
ticulated at the coxofemoral (hip) or
scapulohumeral (shoulder) joint. "Ampu
tation is very cosmetic and most of our
patients can ambulate well on three legs
and are incredibly happy," said Dr.
Kapatkin.
Li mb sparing is the other surgical ap
proach. Here, the tumor is resected en
bloc with 3-5 cm margins, and the gap is
filled with bone graft or donor bone. Po
tential complications include infection,
implant failure and tumor recurrence.
However, the survival rate is the same
for limb-spari ng as for amputation.
Surgery can be performed also to e x
cise metastases. Prolonged survival rates
have been achieved in cases where three
or fewer nodules were present and sur
vival until metastasis was diagnosed ra

diographically was 300+ days, Dr.
Kapatkin said.
Radiation therapy can be potent in de
stroying neo plas tic cells at the primary
tumor site an d che motherapy may be em
ployed to prevent or delay metastasis.
Several drugs - including carboplatin,
cisplatin and doxorubicin, are part of the
osteosarcoma chemotherapy protocol,
which is typically initiated 10-14 days
after surgery. Immunotherapy, which ac
tivates the immune system to combat
cancer cells, is part of newer treatment
protocols.

J.e

Canine Brain Tumors
Brain tumors in dogs are not infre
que nt. Nor are they untreatable. Drs.
C harles Vite and A my Kapatkin clarified
the key issues re volving around brain tu
mors in dogs and their surgical biopsy.
According to Dr. Vile, post-doctoral
fellow in neurology at VHUP, brain tu
mors are a common cause of neurologi
cal dysfunction in dogs over five years of
age. Primary brain tur·lOr~; ;lrise from
neuroepithelial (i.e. astrocytoma,
oligodendrocytoma, choroid plexus neo
plasm and ependymal tumors) and
meni ngeal ti ssue (meningioma). Brain
tumors can also arise seco ndarily from
surrounding tissues like the nasal cavity
or bone (i.e. nasal carcinoma, chondroma
and osteosarcoma) , or originate from he
matogenous metasta sis from tumors else
where in the body (i.e . malignant
melanoma, hemangiosarcoma and lym
phosarcoma).
Cli nical signs of a brain tumor depend
on the location of the mass. Tumors of
the cerebru m and thalamus may result in
sei7.ure s and depression : tumors of the
cerebell um and brain stem typically re
sult in incoordination and cranial nerve
deficits. "The clinical signs tell us what
part of the brain is affected ," said Dr.
Vite.
A thorough neurological exam should
be performed. O nce the location of the
lesion is determined based on the neuro
logic signs, the lesion is then character
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ized as either neoplastic, inflammatory,
cerebrovascular or degenerative. Because
nothing is pathognomonic for a brain tu
mor except biopsy results, one must
co mp ile a list of differential diagnoses
that can account for the clinical signs.
The factors that go into ranking these
differential diagnoses are patient signal
ment (age, breed and sex), chronicity and
progression of signs, evide nce of focal or
multifocal neurologic disease, and pres
ence of other systemic disease.
F or example, said Dr. Vite, the differ
enti al diagnoses for a six-year-old golden
retriever prese nting with a sudden onset
of generalized seizures include: intracra
nial tumor, encephalitis, metabolic dis
ease and idiopathic epilepsy. Add to this
the dog's history of increasing mental
dullness. and idiopathic epilepsy moves
further down on the lis~. Throw in the
fact that the dog is blind in the right eye
and has right-sided postural deficits and
the clinical picture is now most closely
referable to either a brain tumor or
encephalitis.
A cerebrospinal fluid (CSF) tap, titers
to known organisms capable of causing
encephalitis, and magnetic resonance im
aging (MRI ) of the brain can aid in dis
tinguishing between these two possible
ca uses . However, Dr. Vite added, defini
tive diag nosis of a brain tumor requires
biopsy of the mass.
O nce a brain tumor is tentatively di
agnosed, surgical feasibility is then de
termined. Su rgical success depends on
the type of tumor present and its loca
tioll . said Dr. Ka palkin. assistant profes
sor of orthoped ics and neurosurgery.
M ost meningiomas are treatable with
su rgery and adjunctive therapy, increas
ing a pati ent s's lifespan; p itui tary tu
mors, on the other hand, are not easily
treated. T he cerebrum is the best location
to have a tumor, she added. "We can re
move a whole half of the cerebrum and
you probably wouldn't notice a big dif
ference in your pet."
The three main surgical approaches
are the lateral, transfrontal and suboc
cipital entries. The lateral - or parietal
- approach involves making a curved
incision and elevating the muscles over
the parietal bone. A hole is then drilled in

the bone and the cerebrum is accessed. In
the transfrontal approach, the frontal si
nus is penetrated and the frontal bone is
removed using a bone saw. The tumor is
removed from the prefrontal area and the
bone is replaced. The suboccipital ap
proach, used to enter the cerebellum or
brainstem. involves a midline inci,ion
made at the caudal aspect of the skull.
Care must be taken to avoid potentially
lethal laceration of the sinuses in this re
gion. A fourt h approach, the ventral ap
proach, is made through the oral cavity.
Used main ly to access pituitary
microadenomas, this approach carries
high ri sk of in fection. Treatment of pitu
itary tumors may incorporate radiation as
a substitute for - or adjunct to 
surgery.
In addition to sophisticated surgical
tec hniques, Dr. Kapatkin credits ad
vanced post-operative care with the high
success rate for brain surgery. Intensive
care. including fluids and ventilator
th erapy, is pro vided afte r ~u rgery to pre
vent or rapidly respond to potential com
plications, such as seizures, surges in
intracranial pressure. and intracranial
hem orrhage. Fortunately, most patients
su ffer no complications. I n fact, sh e said.
" Seventy-five percent of pat ien ts we do
brain surgery on literally eat dinner the
same day of their surgery."
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Mammary Cancer
Tu mors of the canine mam mary gland
are common. T hey comprise 52% of all
tumors in the intact female dog and oc
cur most often between 10 and 11 years
of age. The breeds most highly repre
sented are spaniels, terriers. German
shepherds as well as toy and miniature
poodles. M ammary gland tumors are of
ten associated with early estrogen expo
sure. "The risk for tumor development is
associated with estrogen exposure during
the first few years of life and that has a
significant importance when it comes to
preventing these tumors" said Dr. Kari n
Sorenmo, assistant professor of oncol
ogy. When a dog is spayed before the

first estrus, she has a 0.5% chance of de
veloping breast cancer later in life. If she
is spayed before the second eslru s there
is an 8% chance of deve loping breast
cancer, and spaying a fter the third estrus
- or any estrus therea fter - increases
the like lihood of mammary can cer to
26%. In dogs th at were spayed in addi
tion to having the tu mor rem oved the
median surv ival was 659 days. Whereas ,
dogs that were le ft intact afte r the ir treat
ment surgery had a median survi val of
only 19 8 days.
The rel ationship between es trogen
and mammary cancer in ca nines is also
important because there are similarities
with estrogen and breast cancer in
women. Wo men w ith breast cancer are
usually middle aged to older - the same
age di.stribution seen in dogs. T he most
common types of tumors in dogs are the
same as those fo und in women. C an ine
estrogen positi ve tumors respond to hor
monal lherapy by removing the ovaries.
Estrogen p o~ it iv e tumors in women re
spond to Tamoxifen which is an anti
estrogen. Both dogs with mamm ary
gland tumors and wo men with breast
cancer can be treated very effectively if
th e tumors are sma ll and there is no ev i
dence of met as tasi~. A nd both canine and
human patients w ilh large pri mary tu
mors or metastatic tumors are at high
ris k for dying fro m the d isease. HI think
that dogs can provide some very interest
ing and valuable models for this disease
in wo men" sa id Dr. Sorenmo .
It has beell re ported [hal about half of
the dogs wi th mamma ry gland tumors
will actual ly have multiple masses . The
caudal gl ands are affecte d more fre
quently. Mam mary tum ors can feel firm,
soft or thickened and vary widely in size.
They may be ulcerated. infl amed or
edematous and one can not determine if
they are malignant or ben ign from these
signs. "The good thing is that even
though this is a very common type of tu
mor in the in tact female dog, half are
likely to be ben ign. " To obta in a diagno
sis, a wide-margi n excisional is per
forme d if the surgical marg ins are clcan
this is also the treat ment of choice for the
primary tumor. However. it is neces sary
(continued on page 26)
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to first evaluate the patient's general
health through blood analysis and to look
for possible systemic spread of the can
cer with chest radiographs. If there is
lymph node involvement then the risk for
developing distant metastasis in the
lungs is much higher.
Once the tumor type has been deter
mined from the biopsy, and the extent of
disease has been determined by one
work-up, it is possible to suggest an out
come as well as an appropriate treatment.
Several good retrospective studies indi
cate that survival rates are higher for
dogs with small tumors . T umors that are
made up of well differentiated cell s are
likely to have a better prognosis than tu
mors that are anaplastic and have a high
mitoti c index. Invasive tumors can be
more likely to metastasize tha n encapsu
lated ones. In general, tu mors that have
metastasized, have a much poorer
prognosis.
The best treatment option is surgical
resection. If the tumor is small it can be
effectively treated with a lumpectomy or
a mastectomy. A large tumor or tumors in
multiple glands require a broad approach
- regional or radical mastectomy - in
order to remove all the malignant tissue s
at the primary site. It is thought that the
progression of thes tumors is dependent
upon the presence of estrogen and an
ovariohysterectomy - removal of the
ovaries - makes it less likel y that the
tumor will continue to grow. Chemo
therapy is indicated in dogs that have
multiple negative prognostIc factors and
lymph node metastasis . More work need s
to be undertaken in thi s area bec ause
there are no controlled stu dies to docu
ment the effeclivent:SS of adjuvant che
motherapy after surgery in dogs with
high risk mammary gland tumors.
The owner has a significant role in
preventing canine mammary gland tu
mors through early detection. All tumors
start out small and often appear insidi
ously. Therefore. it is important for the
owner to either examine their dog's
glands or provide for regul ar veterinary
check ups. There is one retrospective
study from the Un iversity of Pennsylva
nia that found 95% of dogs with mam
mary gland tumors were likely to be
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overweight during their first year of life.
By feeding a balanced diet, spaying early
and providing regular examination of the
mammary glands, the pet owner may sig
nificantly reduce the chances of tumor
development. All tumors should be re
moved and biopsied because early treat
ment is crucial for a good outcome. Do
not watch and wait.

M.R.

From the Laboratory Bench
to the Patient's Bedside
New research in angiogenesi s - or
neovascularization - and its regulation
has led to the discovery that inhibitors
of this process are potent and promising
anti-tumor drugs. "While this work is in
its early stages we are very hopeful th at
we can make a contribution to thi s
growing field" said Dr. Andrei
Tikhonenko, assistant professor of pa
thology.
In the normal adult body there is
very little angiogenesis apart from
wound healing and menstrual cycling.
When angiogenesis occurs, a new blood
vessel sprouts from the pre-existing
one . The membrane surrounding the
original vessel dissociates and the en
dothelial cells migrate and undergo self
proliferation. Cancer biologists and doc
tors have known for years that almost
all malignant tumors are heavily vascu
larized. The tumor is penetrated by a
tightly knit network of s ma ll blood cap
illaries which supply blood and feed the
tumor with oxygen and nutrients . If an
giogenesis can be controlled then it m ay
be possible to cut off the blood s upply
to the tumor and prevent its growth.
This concept is attracti ve bec ause tumor
cells are capable of rapidly accumulat
ing mutation and becoming resistant to
chemotherapy and other therapies.
Within the last three to four ye ars
some of the molecules which are re
sponsible for endothelial cell growth
were identified. Most cells in the body
- including tumor cells - secrete both
inhibitors and activators of angiogen
esis. However, normal ti ss ues secrete

more repressors than activators while
tumor cell s secrete either more activa
tors or le ss repressors and turn the an
giogenic "switch" on. Some of the
molecules that have been identified are:
Vascular Endothelial Growth Factor 
the most potent activator of angiogen
esis - as well as some inhibitors such
as Thrombospondin 1. There are other
even more potent inhibitors such as
some members of the Interleukin family
and Angiostatin, and the most recent ad
dition to the list is a protein called
Endo statin.
In a recent study published in Nature
magazine, a purified form of Endostatin
- a very potent inhibitor of angiogen
esis - was used. Tumors treated with
Endostatin regressed very rapidly. The
tumor cell s remained, but, in the ab
sence of blood vasculature they did not
grow and slowly regressed. When the
therapy was discontinued the tumor
cell s regrouped and formed another tu
mor. If Endostatin therapy was given
again, the tumor regressed again but
grew back as soon as therapy was
stopped. Surprisingly, after twelve to
fourteen cycles the ability of the tumor
to grow back was lost. Still, the problem
is that Endostatin therapy is too costly
for prolonged use.
One type of tumor may be more sen
s itive to Endostatin - tumors of the en
dotheli a l cells themselves. In canines
this tumor is often known as heman
giosarcoma . Hemangiosarcoma is a very
malignant tumor and is capable of me
tas tasis and dissemination. Thi s tumor is
often fatal for the dog. It most com
monly affects the spleen or the right
atrium of the heart, particularly in
German shepherds. Hemangiosa rcomas
are comprised of chaotically arranged
endothelial cells and may not res pond to
all of the inhibitors of angiogenesi s in
the same way that normal endothelia l
cells do. "We are poised to test th e nu
merous inhibitors of angiogenesis and
measure their ability to inhibit the
growth and viability of hemangio
sarcoma cells," explained Dr.
Tikhonenko.
M.R.

